Network origin in Marius Pop first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marius Pop via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder Founder Founder Founder | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman Private Equity Investor | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder Founder | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Founder Founder Chief Executive Officer | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder | |
| Breakthrough Services LLC | Director/Board Member Chairman | ||
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Chief Investment Officer | ||
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman | |
| Weizmann Institute of Science | College/University | Graduate Degree | |
| UCLA Institute of Urologic Oncology | Director/Board Member | ||
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal | |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Biotechnology | Director/Board Member | |
Bellco Capital LLC
 Bellco Capital LLC Investment ManagersFinance Bellco Capital LLC provides investment advisory services. It focuses on deploying capital to create and support companies in life science, real estate, consumer products, media, and other sectors. The company was founded by Rebecka Belldegrun and Arie Belldegrun in 2003 and is headquartered in Los Angeles, CA. | Investment Managers | Founder | |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Los Angeles Economy & Jobs Committee | Corporate Officer/Principal | ||
Ginkgo Bioworks, Inc.
 Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Ginkgo Bioworks, Inc. engages in the development of microbe for different applications. Its organisms can be used for fuels, flavorings, fragrances, cosmetics, and pharmaceutical products. The company was founded by Thomas F. Knight Jr., Austin Che, Reshma Shetty, Bartholomew Canton and Jason Kelly in 2008 and is headquartered in Boston, MA. | Information Technology Services | Director/Board Member | |
| The American Association of Genitourinary Surgeons | Corporate Officer/Principal | ||
| Bioscience for the State of California | Director/Board Member | ||
| Fordham University School of Law | College/University | Graduate Degree | |
| GINKGO BIOWORKS HOLDINGS, INC. | Medical/Nursing Services | Director/Board Member | |
| The Hebrew University Hadassah Medical School | College/University | Doctorate Degree | |
David H. Koch Institute for Integrative Cancer Research
 David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Ligon Discovery, Inc.
 Ligon Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Ligon Discovery's primary technology platform, Small-Molecule Microarrays (SMMs), fundamentally transforms drug discovery by bringing the power of microarrays to target screening. SMMs, developed at Harvard University and the Broad Institute, use a proprietary surface chemistry to attach unmodified chemical collections to a solid surface, enabling massively-parallel screening against protein targets of any function. The scale and scope of SMMs permit a paradigmatic change in drug discovery strategy as entire protein families, molecular pathways, and even genome-wide target sets can be screened in parallel to rapidly identify small molecules with optimal characteristics for drug development. Ligon is applying SMM technology to challenging, novel targets aimed at discovery of first-in-class drugs for oncology and other selected diseases. Ligon Discovery's SMM platform is available for drug discovery collaborations. | Miscellaneous Commercial Services | Founder | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
Ankyra Therapeutics, Inc.
 Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA. | Medical/Nursing Services | Founder | |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
| The University of New Mexico | College/University | Undergraduate Degree | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Founder | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree |
Statistics
International
| United States | 47 |
| Israel | 4 |
| China | 2 |
Sectoral
| Health Technology | 19 |
| Finance | 11 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Health Services | 3 |
Operational
| Director/Board Member | 71 |
| Founder | 39 |
| Corporate Officer/Principal | 19 |
| Chairman | 15 |
| Independent Dir/Board Member | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| David Tanen | 25 |
| K. Wittrup | 14 |
| Christopher Wilfong | 5 |
| Angela Koehler | 4 |
- Stock Market
- Insiders
- Marius Pop
- Company connections
